Screening of gastric cancer

위암의 조기검진

  • Published : 2010.09.01

Abstract

Gastric cancer is the most common malignancy and the second leading cause of cancer-related death in Korea. The proportion of early gastric cancer among surgically treated patients with gastric cancer has been increasing (47.4% in 2004). Gastric cancer detected in early stage can be cured by endoscopic resection or less invasive surgical treatment and the subsequent prognosis is excellent. National cancer screening program for gastric cancer has been available for several years. Efforts to evaluate the efficacy of our screening strategy should be made in terms of mortality reduction and cost-effectiveness.

Keywords

References

  1. Choi IJ. Gastric cancer screening and diagnosis. Korean J Gastroenterol 54:67-76, 2009 https://doi.org/10.4166/kjg.2009.54.2.67
  2. 보건복지가족부, 국립암센터, 국가암정보센터. Avail from: http://www.cancer.go.kr/cms/statics/incidence/index.html#1
  3. Ministry for Health, Welfare and Family Affairs. Annual report of the Korea Central Cancer Registry. 2008
  4. Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J 81:419-424, 2005 https://doi.org/10.1136/pgmj.2004.029330
  5. Korea Gastric Cancer Association. Nationwide gastric cancer report in Korea. J Korean Gastric Cancer Assoc 2:105-114, 2002
  6. Kong SH, Park DJ, Lee HJ, Jung HC, Lee KU, Choe KJ, Yang HK. Clinicopathologic features of asymptomatic gastric adenocarcinoma patients in Korea. Jpn J Clin Oncol 34:1-7, 2004 https://doi.org/10.1093/jjco/hyh009
  7. Korean Gastric Cancer Association. 2004 nationwide gastric cancer report in Korea. J Korean Gastric Cancer 7:47-54, 2007
  8. Lee HJ, Chung JM, Seo EH, Jeon SW. Clinicopathologic characteristics of gastric cancer diagnosed at health screening. Korean J Med 75:665-672, 2008
  9. Nam SY, Choi IJ, Park KW, Kim CG, Lee JY, Kook MC, Lee JS, Park SR, Lee JH, Ryu KW, Kim YW. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol 21:855-860, 2009 https://doi.org/10.1097/MEG.0b013e328318ed42
  10. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48:225-229, 2001 https://doi.org/10.1136/gut.48.2.225
  11. Ministry for Health, Welfare and Family Affairs & National Cancer Center. Cancer Facts and Figures. 2008
  12. Choi KS, Kwak MS, Lee HY, Jun JK, Hahm MI, Park EC. Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series. Cancer Epidemiol Biomarkers Prev 18:1390-1398, 2009 https://doi.org/10.1158/1055-9965.EPI-08-0940
  13. Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer 3:9-18, 2000 https://doi.org/10.1007/PL00011692
  14. Kim NY, Chung IS, Baik GH, Kim JW, Kim HJ, Chung MG, Park SM, Park JY, Nah BK, Nam SY, Seo KS, Ko BM, Jang JY, Kim BG, Kim JW, Park JJ, Hong SJ, Seong JK, Park KS, Kim SE, Park HS, Kim YS, Lim SH, Kim CH, Park MJ, Yim JY, Cho KR, Kim DH, Park SJ, Jee SR, Song GA. Distribution of upper gastroduodenal diseases in health check-up subjects in 2006. Korean J Helicobacter Upper Gastrointest Res 8:1-8, 2008
  15. Gates TJ. Screening for cancer: evaluating the evidence. Am Fam Physician 63:513-522, 2001
  16. Miyamoto A, Kuriyama S, Nishino Y, Tsubono Y, Nakaya N, Ohmori K, Kurashima K, Shibuya D, Tsuji I. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Prev Med 44:12-19, 2007 https://doi.org/10.1016/j.ypmed.2006.07.016
  17. Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 38:829-833, 1986 https://doi.org/10.1002/ijc.2910380608
  18. Fukao A, Tsubono Y, Tsuji I, Hisamichi S, Sugahara N, Takano A. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study. Int J Cancer 60:45-48, 1995 https://doi.org/10.1002/ijc.2910600106
  19. Abe Y, Mitsushima T, Nagatani K, Ikuma H, Minamihara Y. Epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case-control study: a study of a efficient screening programm for stomach cancer. Nippon Shokakibyo Gakkai Zasshi 92:836-845, 1995
  20. Hisamichi S, Sugawara N. Mass screening for gastric cancer by X-ray examination. Jpn J Clin Oncol 14:211-223, 1984
  21. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer 118:2315-2321, 2006 https://doi.org/10.1002/ijc.21664
  22. Inaba S, Hirayama H, Nagata C, Kurisu Y, Takatsuka N, Kawakami N, Shimizu H. Evaluation of a screening program on reduction of gastric cancer mortality in Japan: preliminary results from a cohort study. Prev Med 29:102-106, 1999 https://doi.org/10.1006/pmed.1999.0507
  23. Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K, Kondo T, Kikuchi S, Toyoshima H, Hayakawa N, Tamakoshi A, Ohno Y, Fujino Y, Kaneko S. Prospective study of screening for stomach cancer in Japan. Int J Cancer 106:103-107, 2003 https://doi.org/10.1002/ijc.11183
  24. Oshima A, Hanai A, Fujimoto I. Evaluation of a mass screening program for stomach cancer. Natl Cancer Inst Monogr 181-186, 1979
  25. Hosokawa O, Miyanaga T, Kaizaki Y, Hattori M, Dohden K, Ohta K, Itou Y, Aoyagi H. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand J Gastroenterol 43:1112-1115, 2008 https://doi.org/10.1080/00365520802085395
  26. Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer 116:2941-2953, 2010 https://doi.org/10.1002/cncr.25030
  27. Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol 4:709-716, 2006 https://doi.org/10.1016/j.cgh.2006.03.025
  28. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol 12:4873-4874, 2006
  29. Mori Y, Arita T, Shimoda K, Yasuda K, Yoshida T, Kitano S. Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival. Gastric Cancer 4:132-136, 2001 https://doi.org/10.1007/PL00011735
  30. Aida K, Yoshikawa H, Mochizuki C, Mori A, Muto S, Fukuda T, Otsuki M. Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup. J Gastroenterol Hepatol 23:632-637, 2008 https://doi.org/10.1111/j.1440-1746.2008.05346.x
  31. Riecken B, Pfeiffer R, Ma JL, Jin ML, Li JY, Liu WD, Zhang L, Chang YS, Gail MH, You WC. No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med 34:22-28, 2002 https://doi.org/10.1006/pmed.2001.0925
  32. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735-6740, 1992
  33. Yamamoto M, Yamanaka T, Baba H, Kakeji Y, Maehara Y. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma. J Surg Oncol 97:231-235, 2008 https://doi.org/10.1002/jso.20946
  34. Kim HJ, Lee JH, Lee JS, Moon TG, Kim JJ, Rhee JC, Noh JH, Sohn TS, Kim S. Clinicopathologic characteristics of multiple synchronous early gastric cancers. Korean J Med 72:360-367, 2007
  35. Lee HL, Eun CS, Lee OY, Han DS, Yoon BC, Choi HS, Hahm JS, Koh DH. When do we miss synchronous gastric neoplasms with endoscopy? Gastrointest Endosc 71:1159-1165, 2010 https://doi.org/10.1016/j.gie.2010.01.011